Advera Health Analytics Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Advera Health Analytics's estimated annual revenue is currently $1.1M per year.
- Advera Health Analytics's estimated revenue per employee is $84,000
Employee Data
- Advera Health Analytics has 13 Employees.
Advera Health Analytics Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.8M | 76 | 3% | $3M | N/A |
#2 | $1.2M | 6 | N/A | N/A | N/A |
#3 | $20.9M | 104 | 30% | $176.6M | N/A |
#4 | $39060M | 69756 | 15% | $30 b | $234.4B |
#5 | $108.1M | 538 | N/A | N/A | N/A |
#6 | $24.7M | 155 | N/A | N/A | N/A |
#7 | $124.8M | 938 | 34% | $567.2M | $2.2B |
#8 | $0.8M | 5 | N/A | N/A | N/A |
#9 | $2360M | 3887 | 10% | $22.5M | $10.7B |
#10 | $10.1M | 65 | N/A | N/A | N/A |
#11 | $275.4M | 1220 | 11% | N/A | $4.4B |
#12 | $7M | 45 | N/A | N/A | N/A |
#13 | $21.6M | 88 | -6% | N/A | N/A |
#14 | $0.1M | 4 | N/A | N/A | N/A |
#15 | $2.6M | 26 | N/A | N/A | N/A |
#16 | $71.6M | 462 | N/A | N/A | N/A |
#17 | $46.5M | 264 | 14% | $396M | $424.9M |
#18 | $6.8M | 44 | N/A | N/A | N/A |
#19 | $0.4M | 8 | N/A | N/A | N/A |
#20 | $188.8M | 930 | N/A | N/A | N/A |
What Is Advera Health Analytics?
N/A
Total Funding
13
Number of Employees
$1.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Advera Health Analytics News
2021-07-26 - Advera Health Analytics Launches COVID-19 Vaccine Safety Module on Evidex Platform
SANTA ROSA, Calif. (PRWEB) July 26, 2021 Advera Health Analytics, a market leader in cloud-based software and data-as-a-service drug safety solutions, today announced that it has launched a comprehensive Vaccine Safety Signal Detection and Management module on its market-leading Evidex platform ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 13 | -13% | N/A |
#2 | $7.5M | 15 | 7% | N/A |
#3 | $2.4M | 16 | 14% | N/A |
#4 | $2.9M | 18 | -18% | N/A |
#5 | $1.1M | 19 | 73% | N/A |